Gitnux/Report 2026

AI Prior Authorization Industry Statistics

The AI-based prior authorization market is projected at $1.74 billion in 2026, explore how adoption, networks, and authorization throughput figures connect across growth and company capabilities.
22Statistics
24Sources
4Sections
1Visuals
15mRead
AI Prior Authorization Industry Statistics
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The AI prior authorization industry at a glance

The AI-based prior authorization market is projected at $1.74 billion in 2026, while adoption is expanding as insurers apply AI to review high volumes of authorization requests and meet new automation requirements.

$1.74B[13]
Market size, 2026
19.38%[13]
Forecast CAGR, 2026–2031
70%[1]
Insurers using or exploring AI, 2025
52.8M[14]
Medicare Advantage determinations, 2024
Market size
The AI-based prior authorization market was estimated at $1.50 billion in 2025 and is projected to reach $1.74 billion in 2026. The same forecast places the market at $4.21 billion by 2031.[13]
Forecast & CAGR
The market is forecast to expand at a 19.38% compound annual growth rate from 2026 to 2031, according to Mordor Intelligence’s market estimate.[13]
Segmentation
AI prior authorization solutions are divided between payer- and provider-oriented products, with offerings including predictive and generative AI. Use cases include determining whether authorization is required and reviewing requests for approval; in the NAIC survey, 44% of responding insurers reported using, planning to use, or exploring AI for the former use case, while 70% reported this for approval review.[2][1]
Key players & concentration
The market includes health-plan technology vendors and specialist automation companies. In 2025, Infinx acquired Glidian, a prior authorization automation company with a stated laboratory-market focus; among six large Medicare Advantage insurers analyzed by KFF, standard denial rates ranged from 5% at Elevance to 17% at UnitedHealth Group, indicating material variation among major payer participants.[15][14]
Trends, drivers & challenges
Demand is driven by administrative volume, staffing pressure, and regulatory efforts to make prior authorization more electronic and interoperable. In 2024, fully electronic medical-plan prior authorization represented 35% of transactions, while 22% remained fully manual; MACPAC identifies predictive AI as one tool for reducing delays and improving workflow decisions.[16]
Consumer behavior & competition
Prior authorization affects nearly all Medicare Advantage enrollees: 99% were required to obtain authorization for at least some services in 2024. Medicare Advantage insurers processed 52.8 million determinations, with 7.7% fully or partially denied; among the six insurers assessed by KFF, standard denial rates ranged from 5% to 17%.[14]
M&A
Infinx announced its acquisition of Glidian on March 17, 2025. The transaction was positioned as a way to combine Glidian’s prior authorization automation capabilities, particularly in laboratories, with Infinx’s broader patient-access and revenue-cycle platform; financial terms were not disclosed.[15]
Regulation
CMS’s prior authorization framework requires greater interoperability and reporting across Medicare Advantage, Medicaid, CHIP, and federally facilitated Marketplace plans. MACPAC’s June 2026 report describes automation options including predictive AI, while KFF reports that the CMS WISeR model began on January 1, 2026, testing enhanced technology for additional traditional Medicare services in six states.[16][14]
Latest news
The latest major policy development identified is the January 1, 2026 launch of CMS’s WISeR model, which tests enhanced technology for prior authorization of selected traditional Medicare services in six states. KFF also reported in January 2026 that Medicare Advantage insurers processed 52.8 million prior authorization determinations in 2024.[14]

02 Ranking

Top 10 Companies in the AI Prior Authorization Industry

The leading companies in the AI prior authorization industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

Cohere Health stands out for payer prior authorization request processing because it processes more than 5.6 million intelligent prior authorization requests annually, while AKASA focuses on provider submission automation since its Authorization Advisor uses generative AI to complete authorization submissions and find clinical documents.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in payer AI authorization software

    Cohere Health

    US

    Ranked #1 · 9.1 · Payer AI authorization software

    Why we picked it: Its AI clinical intelligence for payer prior authorization centers on high-volume request processing.

  2. Leader in provider authorization automation

    AKASA

    US

    Ranked #2 · 9.0 · Provider authorization automation

    Why we picked it: Its Authorization Advisor targets provider prior authorization submission tasks using generative AI.

  3. Leader in electronic prior authorization networks

    McKesson

    US

    Ranked #3 · 8.9 · Electronic prior authorization networks

    Why we picked it: Its electronic pharmacy prior authorization network supports medication authorization workflows.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the AI prior authorization industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Cohere Health

Payer AI authorization software · US

9.1
2

AKASA

Provider authorization automation · US

9.0
3

McKesson

Electronic prior authorization networks · US

8.9
4

HealthEdge

Health-plan utilization management AI · US

8.9
5

Surescripts

Electronic prior authorization networks · US

8.9
6

Waystar

Provider revenue-cycle prior authorization automation · US

8.8
7

Experian

Experian Health provider authorization automation · IE

8.8
8

Availity

Payer-provider network and intelligent utilization management · US

8.7
9

SamaCare

Specialty-drug prior authorization automation · US

8.5
10

UnitedHealth Group

Optum prior authorization and utilization management · US

8.4

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 10 companies in the AI prior authorization industry. In AI Prior Authorization Industry Statistics. Gitnux. https://gitnux.org/ai-prior-authorization-industry-statistics/#top-companies

report visual · Comparison

Distribution of surveyed U.S. health systems by AI implementation stage for streamlining prior authorization

Developing or piloting holds the largest share at 59%.

Developing or piloting59%
No activity22%
Deployed fully15%
Deploying in limited areas5%
source-verifiedpmc.ncbi.nlm.nih.gov

04 Statistics

Technology & AI

Insurers report production deployment for AI/ML in approval review, with 70% deploying it in production and 71% using, planning, or exploring it in the 2025 NAIC survey.

AI features and adoption in the AI prior authorization industry

  • 70% of surveyed health insurers that used, planned to use or explored AI/ML for prior-authorization approval review reported production deployment.[1]
  • 71% of surveyed health insurers currently used, planned to use or were exploring AI/ML to review prior authorizations for approval in the 2025 NAIC survey.[1]
  • 41% of surveyed health insurers currently used, planned to use or were exploring AI/ML to determine whether prior authorization was required in the 2025 NAIC survey.[1]
  • 37% of insurers reported using AI currently or within one year for prior authorization, while 70% of large-employer-market insurers reported using or exploring it.[2]

05 Statistics

Market Intelligence

The category spans software and broader automation, with $721.9 million estimated for AI-based prior authorization automation in 2025 and growth expected to reach $4.21 billion by 2031.

Market size and revenue in the AI prior authorization industry

  • $3.01 billion was the estimated global 2025 market size for prior authorization automation, including software and broader automation solutions; the study does not isolate AI-only products.[3]
  • $721.9 million was the global 2025 market size for AI-based prior authorization automation software, platforms and services covering payer, provider, pharmacy, PBM and revenue-cycle workflows.[4]

Growth forecasts for the AI prior authorization industry

  • 17.0% is the projected global CAGR for prior authorization automation from 2025 through 2034, with the market forecast to reach $12.37 billion in 2034.[3]
  • 19.38% is the projected global CAGR for AI-based prior authorization from 2026 through 2031, with the market forecast to reach $4.21 billion in 2031.[5]
  • 31.69% is the projected global CAGR for AI-based prior authorization automation from 2026 through 2034, with the market forecast to reach $8.60 billion in 2034.[4]

Product counts and provider structure in the AI prior authorization industry

  • More than 30 companies offered or planned technology-enabled utilization-management or revenue-cycle platforms capable of administering prior authorization, according to CMS.[6]
  • 47 providers were classified as provider-side automation companies in the October 2026 global prior authorization market map.[7]
  • 134 providers were listed in the October 2026 global prior authorization market map across provider-side automation, payer utilization management, pharmacy ePA, voice AI, clearinghouses, FHIR infrastructure and EHR-embedded products.[7]

Regional breakdown of the AI prior authorization industry

  • $1.28 billion was the estimated U.S. 2025 market size within the global prior authorization automation market, whose scope includes broader automation than AI-only products.[3]
  • 57.0% was North America's share of global AI-based prior authorization automation revenue in 2025, equal to $411.5 million.[4]
  • $411.5 million was the North American 2025 market size for AI-based prior authorization automation software, platforms and services.[4]

06 Statistics

Pricing & Packaging

Published entry pricing and AWS Marketplace tiers show per-user and per-request packaging patterns, including $50 per user per month and $8,750 per month for up to 1,000 requests.

Price levels in the AI prior authorization industry

  • $250 per clinic per month was the published Pro price for EasyPA’s AI prior-authorization automation, observed in the United States on November 20, 2026, across a three-product sample.[8]
  • $50 per user per month was the published entry price for EasyPA’s AI prior-authorization automation plan, observed in the United States on November 20, 2026, across a three-product sample.[8]
  • $8,750 per month covered up to 1,000 authorization requests in AWS Marketplace’s Standard tier for an AI prior-authorization agent, observed in the United States on November 20, 2026.[9]
  • $1,750 per month covered up to 200 authorization requests in AWS Marketplace’s Starter tier for an AI prior-authorization agent, observed in the United States on November 20, 2026.[9]

07 Statistics

Finance

Funding disclosures through April 2026 cover three defined entrants, with $96.6 million cumulative funding across Anterior, Develop Health, and Ethermed.

Funding and investment in the AI prior authorization industry

  • Three U.S. AI prior authorization software entrants in a defined observed sample had disclosed funding by April 2026: Anterior, Develop Health and Ethermed.[10]
  • More than $96.6 million in cumulative funding was disclosed by three observed U.S. AI prior authorization software companies—Anterior, Develop Health and Ethermed—through April 2026; this is a defined-sample aggregate, not a category total.[11]
  • $17.6 million was the median cumulative funding among three observed U.S. AI prior authorization software companies—Anterior, Develop Health and Ethermed—through April 2026; this is a defined-sample calculation.[12]

Key questions about the AI prior authorization industry

What is the AI-based prior authorization market size for 2026?
The AI-based prior authorization market is projected at $1.74 billion in 2026.
How fast is the market expected to grow from 2026 to 2031?
The market is forecast to expand at a 19.38% compound annual growth rate from 2026 to 2031, reaching $4.21 billion by 2031.
Which companies lead the AI prior authorization industry?
Cohere Health stands out for payer prior authorization request processing because it processes more than 5.6 million intelligent prior authorization requests annually, while AKASA focuses on provider submission automation since its Authorization Advisor uses generative AI to complete authorization submissions and find clinical documents.
What technology shifts matter most for insurers in 2025–2026?
Insurers report production deployment for AI/ML used in approval review, with 70% deployed in production and 71% using, planning, or exploring for approval review in the 2025 NAIC survey.
How is the market structured between payer and provider offerings?
AI prior authorization solutions split between payer-oriented and provider-oriented products, including predictive and generative AI, with use cases across requiredness and approval review.
What does denial variation imply for decision analytics buyers?
Standard denial rates vary across major Medicare Advantage insurers, ranging from 5% at Elevance to 17% at UnitedHealth Group, which can drive analytics around authorization outcomes.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). AI Prior Authorization Industry Statistics. Gitnux. https://gitnux.org/ai-prior-authorization-industry-statistics
MLA
Samuel Norberg. "AI Prior Authorization Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/ai-prior-authorization-industry-statistics.
Chicago
Samuel Norberg. 2026. "AI Prior Authorization Industry Statistics." Gitnux. https://gitnux.org/ai-prior-authorization-industry-statistics.